Unknown

Dataset Information

0

Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain.


ABSTRACT:

Objective

Moringa oleifera possesses multiple biological effects and the 4-[(4'-O-acetyl-α-L- rhamnosyloxy) benzyl] isothiocyanate accounts for them. Based on the original isothiocyanate molecule we obtained a semisynthetic derivative, named 4-[(2',3',4'-O-triacetyl-α-L-rhamnosyloxy) N-benzyl] hydrazine carbothioamide (MC-H) which was safe and effective in a temporomandibular joint (TMJ) inflammatory hypernociception in rats. Therefore, considering that there is still a gap in the knowledge concerning the mechanisms of action through which the MC-H effects are mediated, this study aimed to investigate the involvement of the adhesion molecules (ICAM-1, CD55), the pathways heme oxygenase-1 (HO-1) and NO/cGMP/PKG/K+ ATP, and the central opioid receptors in the efficacy of the MC-H in a pre-clinical study of TMJ pain.

Methods

Molecular docking studies were performed to test the binding performance of MC-H against the ten targets of interest (ICAM-1, CD55, HO-1, iNOS, soluble cGMP, cGMP-dependent protein kinase (PKG), K+ ATP channel, mu (μ), kappa (κ), and delta (δ) opioid receptors). In in vivo studies, male Wistar rats were treated with MC-H 1 μg/kg before TMJ formalin injection and nociception was evaluated. Periarticular tissues were removed to assess ICAM-1 and CD55 protein levels by Western blotting. To investigate the role of HO-1 and NO/cGMP/PKG/K+ ATP pathways, the inhibitors ZnPP-IX, aminoguanidine, ODQ, KT5823, or glibenclamide were used. To study the involvement of opioid receptors, rats were pre-treated (15 min) with an intrathecal injection of non-selective inhibitor naloxone or with CTOP, naltrindole, or norbinaltorphimine.

Results

All interactions presented acceptable binding energy values (below -6.0 kcal/mol) which suggest MC-H might strongly bind to its molecular targets. MC-H reduced the protein levels of ICAM-1 and CD55 in periarticular tissues. ZnPP-IX, naloxone, CTOP, and naltrindole reversed the antinociceptive effect of MC-H.

Conclusion

MC-H demonstrated antinociceptive and anti-inflammatory effects peripherally by the activation of the HO-1 pathway, as well as through inhibition of the protein levels of adhesion molecules, and centrally by μ and δ opioid receptors.

SUBMITTER: Silveira FD 

PROVIDER: S-EPMC9083263 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From <i>Moringa oleifera</i> in a Pre-clinical Study of Temporomandibular Joint Pain.

Silveira Felipe Dantas FD   Gomes Francisco Isaac Fernandes FIF   do Val Danielle Rocha DR   Freitas Hermany Capistrano HC   de Assis Ellen Lima EL   de Almeida Diana Kelly Castro DKC   Braz Helyson Lucas Bezerra HLB   Barbosa Francisco Geraldo FG   Mafezoli Jair J   da Silva Marcos Reinaldo MR   Jorge Roberta Jeane Bezerra RJB   Clemente-Napimoga Juliana Trindade JT   Costa Deiziane Viana da Silva DVDS   Brito Gerly Anne de Castro GAC   Pinto Vicente de Paulo Teixeira VPT   Cristino-Filho Gerardo G   Bezerra Mirna Marques MM   Chaves Hellíada Vasconcelos HV  

Frontiers in neuroscience 20220425


<h4>Objective</h4><i>Moringa oleifera</i> possesses multiple biological effects and the 4-[(4'-<i>O</i>-acetyl-α-L- rhamnosyloxy) benzyl] isothiocyanate accounts for them. Based on the original isothiocyanate molecule we obtained a semisynthetic derivative, named 4-[(2',3',4'-<i>O</i>-triacetyl-α-L-rhamnosyloxy) <i>N</i>-benzyl] hydrazine carbothioamide (MC-H) which was safe and effective in a temporomandibular joint (TMJ) inflammatory hypernociception in rats. Therefore, considering that there  ...[more]

Similar Datasets

| S-EPMC12347210 | biostudies-literature
| PRJNA1197419 | ENA
| PRJNA304048 | ENA
| PRJNA391762 | ENA
| PRJNA288608 | ENA
| PRJNA510938 | ENA
| PRJNA835993 | ENA
| PRJNA765934 | ENA
| PRJNA1004469 | ENA
2025-06-25 | GSE295404 | GEO